MANIRAM RAMPERSAUD: Open Payments
NPI 1356118855 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $278 · 2025 $403
Food & beverage: $318Education: $85
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $155 |
| Astellas Pharma US Inc | 1 | $85 |
| ABBVIE INC. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Lilly USA, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: OTEZLA, EVENITY, QULIPTA, MOUNJARO, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, BREZTRI.
Industry payments across FL — which companies pay providers there.
